Warning Letter — Waves and Wine, Inc.
The FDA Center for Veterinary Medicine issued a warning letter to Waves and Wine, Inc. on July 6, 2026, following an inspection or review of the company's practices.
Waves and Wine, Inc., as well as regulatory and quality assurance professionals involved in the manufacturing and distribution of products under the jurisdiction of the Center for Veterinary Medicine.
This enforcement action indicates that the FDA CVM identified significant deviations from regulatory requirements at Waves and Wine, Inc. While the specific violations are not detailed in the provided excerpt, such letters typically involve issues such as the marketing of unapproved new animal drugs or significant CGMP violations, potentially leading to product seizures or injunctions if not addressed.
Conduct an internal audit of all veterinary product listings and marketing claims to ensure alignment with FDA approvals. Regulatory teams should verify that any animal health products currently being marketed are not operating outside the scope of CVM regulations.
FDA Warning Letter issued to: Waves and Wine, Inc.. 07/06/2026 — Center for Veterinary Medicine. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/waves-and-wine-inc-724861-07062026
Open in openFDA / FDA.gov